SPONSOR
Suzhou Forlong Biotechnology Co., Ltd
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Clinical Trials by Suzhou Forlong Biotechnology Co., Ltd
NCT07131202 Phase 1, Phase 2
Recruiting
A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors
Advanced Solid Tumors
NCT07122414 Phase 1, Phase 2
Recruiting
A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology